missing translation for 'onlineSavingsMsg'
Learn More
Learn More
alpha-Synuclein, p Ser129 Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody
Marca: Novus Biologicals NBP2-61121
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
alpha-Synuclein Polyclonal specifically detects alpha-Synuclein in Human, Mouse, Rat samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.
Specifica
| alpha-Synuclein (p Ser129) | |
| Monoclonal | |
| Unconjugated | |
| PBS pH 7.4 and 50% glycerol with 0.09% Sodium Azide | |
| SNCA | |
| This alpha-Synuclein [p Ser129] Antibody was developed against Synthetic peptide of human alpha-Synuclein pSer129 (40-140 aa), conjugated to Keyhole Limpet Hemocyanin (KLH). | |
| 100 μL | |
| Primary | |
| This alpha-Synuclein [p Ser129] Antibody is specific for phosphorylated serine 129 on alpha-synuclein. Does not detect unphosphorylated serine 129 alpha-synuclein. Detects bands at 100, 75, 45, 15 kDa. Bands above 15 kDa are oligomers. | |
| Store at -20C short term. Aliquot and store at -80C long term. Avoid freeze-thaw cycles. |
| Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin) | |
| 0.5 mg/ml | |
| Western Blot 1:1000, ELISA, Immunohistochemistry 1:500, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin 1:500 | |
| Lewy body) 4, MGC110988, non A-beta component of AD amyloid, Non-A beta component of AD amyloid, non-A4 component of amyloid, Non-A4 component of amyloid precursor, PARK1, PARK4, synuclein, alpha (non A4 component of amyloid precursor) | |
| Rabbit | |
| Affinity Purified | |
| Alzheimers Research, Apoptosis, Cell Biology, Cellular Markers, Neurodegeneration, Neuroscience | |
| 6622 | |
| Human, Mouse | |
| IgG |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto